ORDER A TEST
PORTALS

Neoadjuvant therapy

MammaPrint and BluePrint as prognostic indicators for elderly patients with early-stage breast cancer

PUBLICATION: SABCS 2020 AUTHORS: Peter W. Blumencranz, Mehran Habibi, Read More

2024-03-25T08:05:58-04:00December 29th, 2020|Adjuvant, Evidence, MINT, Neoadjuvant|
Go to Top